---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-024663"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2026-07-28T20:03:12+00:00"
generated_at: "2026-07-28T20:04:10.573557+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NRC Health Q2 TRCV up 11% to $151.9M; adj. EPS $0.31 vs. GAAP loss ($0.15)

## Summary
- Total revenue $35.4M, up 4% YoY; GAAP net loss ($3.3M) vs. adjusted net income $6.9M.
- Adjusted EBITDA $9.4M (27% of revenue); free cash flow $0.1M after $2.9M cash payment for accelerated vesting.
- TRCV $151.9M, up 11% YoY; strongest bookings for The Governance Institute in seven years.
- GAAP diluted EPS ($0.15); adjusted diluted EPS $0.31 on 22.0M shares.
- CEO cites double-digit TRCV growth, strong go-to-market execution, and product innovation commercialization.

## SEC filing metadata
- accession: 0001437749-26-024663
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2026-07-28T20:03:12+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774926024663/0001437749-26-024663-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774926024663/nrc20260724_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-024663
- JSON: https://secwatch.observer/filing/0001437749-26-024663.json
- Plain text: https://secwatch.observer/filing/0001437749-26-024663.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.